Top Medical News
6 hours ago
Sodium glucose co-transport-2 (SGLT-2) inhibitors show potential therapeutic value when used as an adjunct to insulin in the management of type 1 diabetes mellitus (T1DM), according to a meta-analysis. The use of SGLT-2 inhibitors appears to effectively improve glycaemic control, reduce body weight and total daily insulin dose without increasing adverse events, as well as lower the incidence of hypoglycaemia or genital and urinary infections.
Yesterday
Excessive consumption of tropical and citrus fruits, as well as fruits with moderate to high glycaemic index values, during the second trimester of pregnancy is likely to increase the occurrence of gestational diabetes mellitus (GDM), according to a study.
Yesterday
Pregnant women who have high intakes of carbohydrate and sugar may give birth to infants with unfavourable body mass index (BMI) peak characteristics and higher early childhood BMI, a recent study has found.
Roshini Claire Anthony, Yesterday

Pregnant women who consume high-protein diets have an elevated risk of gestational diabetes mellitus (GDM), according to findings of the GUSTO* study.

2 days ago
The risk of metabolic syndrome (MS) is associated with liver function in a Chinese population. Age and gender influence this association, a new study shows.
2 days ago
Both the American Thyroid Association (ATA) paediatric risk classification and dynamic risk stratification (DRS) based on the response to initial therapy appear to be useful in predicting recurrent or persistent disease in paediatric patients with differentiated thyroid cancer (DTC), suggest a recent study.
Jairia Dela Cruz, 4 days ago
The circular RNA (circRNA) hsa_circ_0054633 may be useful in the diagnosis of prediabetes and type 2 diabetes mellitus (T2DM), according to a single-centre study from China.
Special Reports
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
20 Jan 2017
At the recent Malaysian Osteoporosis Society 2016 Clinical Practice Guideline (CPG) Meeting held on the 8th of October 2016 at Ibis Styles Ipoh, Dr Hew Fen Lee and Professor Dr Chan Siew Pheng presented clinical guidance on the management of osteoporosis, and discussed whether the benefits of treatment outweigh the risks.
04 Jan 2017
At the Diabetes Asia 2016 Conference organized by the National Diabetes Institute, Professor Jean Claude Mbanya presented the case for why gliclazide modified release (MR; Diamicron® MR, Servier) should be the treatment of choice for early and aggressive control of type 2 diabetes (T2D).
16 Dec 2016
BASALOG – Insulin glargine (rDNA) 100 IU/mL soln for inj (cartridge) – CCM Pharmaceuticals
16 Dec 2016
INVOKANA – Canagliflozin hemihydrate 100 mg and 300 mg FC tab – Johnson & Johnson (Janssen)
Pearl Toh, 07 Dec 2016
Preventing hypertension, diabetes, and obesity, which are the major risk factors for heart failure (HF), by ages 45 and 55 years may lower risks of incident HF and prolong HF-free survival, suggests data from the Cardiovascular Disease Lifetime Risk Pooling Project.
18 Nov 2016
The prevalence of hypertension is on the rise in Malaysia and many patients require more than one medication to control their BP. However, treatment adherence is a common issue in patient management, particularly when it comes to patients with multiple morbidities requiring numerous medications.1 In this interview, MIMS Doctor spoke to a distinguished endocrinologist about systolic hypertension, diabetes and patient compliance.
Conference Reports
Dr. Joseph Delano Fule Robles, 14 Feb 2017

A recent study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands, shows promise with a breath test measuring five chemicals in the detection of possible gastric and oesophageal cancers. 

Dr. Joseph Delano Fule Robles, 13 Feb 2017

Results from a study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands showed that rapid deterioration of type 2 diabetes after diagnosis may be an early sign of pancreatic cancer. 

Elvira Manzano, 19 Jan 2017
Cyclin-dependent kinase (CDK) 4/6 inhibitors may be a potential game changer in breast cancer therapy, with promising results from the MONALEESA-2 trial sub-analysis showing that ribociclib, in combination with letrozole, significantly improved progression-free survival (PFS) in Asian women with hormone receptor (HR)-positive, HER2-negative advanced breast cancer.
Roshini Claire Anthony, 16 Dec 2016

Five years of extended therapy with the aromatase inhibitor (AI) letrozole did not improve survival in postmenopausal breast cancer patients, according to findings of the NRG Oncology/NSABP B-42 trial presented at the San Antonio Breast Cancer Symposium (SABCS 2016) held in Texas, US. 

Roshini Claire Anthony, 14 Dec 2016

The addition of ibandronate to adjuvant hormonal therapy provides no benefit to postmenopausal women with HR-positive breast cancer, according to early results from the phase III TEAM IIB trial (BOOG 2006-4)*.

Pearl Toh, 21 Nov 2016
Combining bone cortical porosity and trabecular density in assessment of structural deterioration (known as structural fragility score [SFS]) identifies women with imminent fracture risk better than using the fracture risk-assessment tool (FRAX) or bone mineral density (BMD), according to the OFELY* study presented at the 6th Asia-Pacific Osteoporosis Meeting (IOF Regionals 2016) held in Singapore.
Tristan Manalac, 17 Nov 2016
Diabetes and osteoporosis, particularly bone loss, have very complex pathophysiologies, according to an expert who gave a rundown of the current state of osteoporosis and diabetes at the recently concluded 6th Asia-Pacific Osteoporosis Meeting (IOF Regionals 2016) in Singapore.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD